Literature DB >> 15996191

Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

N A Skinner1, C M MacIsaac, J A Hamilton, K Visvanathan.   

Abstract

Rapid overproduction of proinflammatory cytokines are characteristic of sepsis. CD14(dim)CD16(+) monocytes are thought to be major producers of cytokine and have been shown to be elevated in septic patients. Toll-like receptors (TLR) are pattern recognition receptors important in mediating the innate immune response and their activation can lead to production of cytokines. Using whole blood culture and flow cytometry we have investigated TLR2 and TLR4 regulation after stimulation with sepsis-relevant antigens [lipopolysaccharide (LPS), Staphylococcal enterotoxin B (SEB) and peptidoglycan (PGN)]. The percentage of CD14(dim)CD16(+) monocyte population expanded at 20 h post-stimulation, after a rise in tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 at 2 h. A strong positive correlation between the percentage of CD14(dim)CD16(+) monocytes and secreted TNF-alpha was demonstrated (r = 0.72). Furthermore, we were able to induce expansion of the CD14(dim)CD16(+) population to approximately 35% of all monocytes with the addition of recombinant TNF-alpha to the whole blood culture. TLR4 was found to be expressed 2.5 times higher on CD14(dim)CD16(+) compared to CD14(+) CD16(-) monocytes, while TLR2 expression was similar in both subpopulations. The CD14(dim)CD16(+) and CD14(+) CD16(-) monocyte populations were different in their response to various antigens. LPS down-regulated TLR4 by 4.9 times in CD16(+) monocytes compared to only 2.3 times in CD16(-) monocytes at 2 h. LPS was able to up-regulate TLR2 by 6.2 times after 2 h, with no difference between the subpopulations. LPS further up-regulated TLR2 by 18.4 times after 20 h only in the CD14(+) CD16(-) population. PGN and SEB induced no significant changes in TLR2 or TLR4 expression. We hypothesize that following exposure to bacterial antigens, subsequent TNF-alpha drives a differentiation of monocytes into a CD14(dim)CD16(+) subpopulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996191      PMCID: PMC1809439          DOI: 10.1111/j.1365-2249.2005.02839.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Authors:  G Fingerle-Rowson; M Angstwurm; R Andreesen; H W Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 2.  Structure and function of streptococcal and staphylococcal superantigens in septic shock.

Authors:  J Bannan; K Visvanathan; J B Zabriskie
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

3.  Phenotypic changes of monocytes induced by HIV-1 gp120 molecule and its fragments.

Authors:  M Zembala; S Bach; A Szczepanek; G Mancino; V Colizzi
Journal:  Immunobiology       Date:  1997-06       Impact factor: 3.144

4.  Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia.

Authors:  M Blumenstein; P Boekstegers; P Fraunberger; R Andreesen; H W Ziegler-Heitbrock; G Fingerle-Rowson
Journal:  Shock       Date:  1997-07       Impact factor: 3.454

5.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

Review 6.  Outcome of patients with sepsis and septic shock after ICU treatment.

Authors:  M H Schoenberg; M Weiss; P Radermacher
Journal:  Langenbecks Arch Surg       Date:  1998-03       Impact factor: 3.445

7.  The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages.

Authors:  H W Ziegler-Heitbrock; G Fingerle; M Ströbel; W Schraut; F Stelter; C Schütt; B Passlick; A Pforte
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

8.  Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.

Authors:  C Martin; C Boisson; M Haccoun; L Thomachot; J L Mege
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

9.  Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis.

Authors:  M Frankenberger; T Sternsdorf; H Pechumer; A Pforte; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

Review 10.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

View more
  39 in total

1.  The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum.

Authors:  Stephen Booth; Geraint D Florida-James; Brian K McFarlin; Guillaume Spielmann; Daniel P O'Connor; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2010-08-27       Impact factor: 3.078

2.  Expansion of CD14+CD16+ peripheral monocytes among patients with aseptic loosening.

Authors:  W Wu; X Zhang; C Zhang; T Tang; W Ren; K Dai
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

Review 3.  Monocyte subsets and their differentiation tendency after burn injury.

Authors:  Guangqing Wang; Zhaofan Xia
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

4.  The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease.

Authors:  Michael Gleeson; Nicolette C Bishop; David J Stensel; Martin R Lindley; Sarabjit S Mastana; Myra A Nimmo
Journal:  Nat Rev Immunol       Date:  2011-08-05       Impact factor: 53.106

5.  CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Authors:  Baoying Liu; Ashwin Dhanda; Sima Hirani; Emily L Williams; H Nida Sen; Fernando Martinez Estrada; Diamond Ling; Ian Thompson; Megan Casady; Zhiyu Li; Han Si; William Tucker; Lai Wei; Shayma Jawad; Amol Sura; Jennifer Dailey; Susan Hannes; Ping Chen; Jason L Chien; Siamon Gordon; Richard W J Lee; Robert B Nussenblatt
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

Review 6.  The macrophage: the intersection between HIV infection and atherosclerosis.

Authors:  Suzanne M Crowe; Clare L V Westhorpe; Nigora Mukhamedova; Anthony Jaworowski; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

7.  Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns.

Authors:  Sigifredo Pedraza-Sánchez; Amy G Hise; Lakshmi Ramachandra; Fabian Arechavaleta-Velasco; Christopher L King
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

Review 8.  Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections.

Authors:  Mouhannad Sadek; Feng Yun Yue; Erika Yue Lee; Gabor Gyenes; R Brad Jones; Victor Hoffstein; David G Munoz; Ignatius Fong; Mario Ostrowski
Journal:  Clin Vaccine Immunol       Date:  2008-08-13

9.  A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.

Authors:  Pattamawan Chimma; Christian Roussilhon; Panudda Sratongno; Ronnatrai Ruangveerayuth; Kovit Pattanapanyasat; Jean-Louis Pérignon; David J Roberts; Pierre Druilhe
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.

Authors:  Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.